Peter Dritschilo
President at SHUTTLE PHARMACEUTICALS HOLDINGS, INC.
Net worth: 3 483 $ as of 2024-05-30
Peter Dritschilo active positions
Companies | Position | Start | End |
---|---|---|---|
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | President | 2012-12-17 | - |
Chief Operating Officer | 2012-12-17 | - | |
Director/Board Member | 2012-12-17 | - | |
Shuttle Pharmaceuticals, Inc.
Shuttle Pharmaceuticals, Inc. BiotechnologyHealth Technology Shuttle Pharmaceuticals, Inc. operates as a pharmaceutical company which engages in the development and commercialization of drugs. It focuses on innovative drugs for sensitizing cancers to and protecting normal tissue from the effects of radiation therapy. The firm's products include novel HDAC inhibitor cancer drug candidates. The company was founded by Anatoly Dritschilo, Milton Brown, and Mira Jung in December 2012 and is headquartered in Rockville, MD. | Chief Operating Officer | 2012-11-30 | - |
President | 2012-11-30 | - |
Career history of Peter Dritschilo
Training of Peter Dritschilo
Georgetown University | Undergraduate Degree |
The GW School of Business | Masters Business Admin |
Statistics
International
United States | 5 |
Operational
Chief Operating Officer | 2 |
President | 2 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 3 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
Private companies | 1 |
---|---|
Shuttle Pharmaceuticals, Inc.
Shuttle Pharmaceuticals, Inc. BiotechnologyHealth Technology Shuttle Pharmaceuticals, Inc. operates as a pharmaceutical company which engages in the development and commercialization of drugs. It focuses on innovative drugs for sensitizing cancers to and protecting normal tissue from the effects of radiation therapy. The firm's products include novel HDAC inhibitor cancer drug candidates. The company was founded by Anatoly Dritschilo, Milton Brown, and Mira Jung in December 2012 and is headquartered in Rockville, MD. | Health Technology |
- Stock Market
- Insiders
- Peter Dritschilo
- Experience